Statement Of Cash Flows [Abstract]

SIPEF - Filing #3199898

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
2 369 USD
4 330 USD
Cash flows from (used in) operations before changes in working capital
178 796 USD
73 669 USD
Increase (decrease) in working capital
8 523 USD
3 165 USD
Adjustments for decrease (increase) in trade and other receivables
0 USD
0 USD
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables
0 USD
249,000 USD
Adjustments for gains (losses) on change in fair value less costs to sell, biological assets
2 404 USD
733,000 USD
Adjustments for gains (losses) on change in fair value of derivatives
2 178 USD
1 171 USD
Adjustments for gain (loss) on disposals, property, plant and equipment
1 241 USD
957,000 USD
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
0 USD
0 USD
Income taxes paid, classified as operating activities
9 962 USD
3 572 USD
Cash flows from (used in) investing activities [abstract]
Dividends received from investments accounted for using equity method, classified as investing activities
0 USD
0 USD
Purchase of investment property
0 USD
0 USD
Purchase of biological assets
27 396 USD
26 971 USD
Cash flows from (used in) financing activities [abstract]
Dividends paid to equity holders of parent, classified as financing activities
4 443 USD
0 USD
Dividends paid to non-controlling interests, classified as financing activities
2 306 USD
716,000 USD
Proceeds from sale or issue of treasury shares
1 033 USD
0 USD
Proceeds from non-current borrowings
0 USD
0 USD
Repayments of non-current borrowings
18 078 USD
9 228 USD
Proceeds from current borrowings
0 USD
0 USD
Repayments of current borrowings
73 710 USD
5 092 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.